Keyphrases
LAMP2
100%
Prostate Cancer
100%
Autophagy Pathway
100%
Up-regulated Expression
100%
Neuroendocrine Differentiation
100%
LNCaP Cells
100%
Neuroendocrine Cells
77%
ATG5
44%
Autophagy
33%
Blockage
22%
Cell Survival
22%
Quantitative PCR
22%
Western Blot
22%
AKT Inhibitor
22%
Serum Deprivation
22%
Neuroendocrine Markers
22%
Beclin-1
22%
Neuroendocrine Prostate Cancer
22%
Overexpression
11%
Cell Culture
11%
Tubulin
11%
Cell Differentiation
11%
Small Interfering RNA (siRNA)
11%
Knockdown
11%
Protein Level
11%
Autophagosome
11%
LNCaP
11%
Prostate Cancer Cells
11%
Gene Expression Profile
11%
Confocal Microscopy
11%
Androgen Receptor
11%
Cancer-related
11%
Enhanced Expression
11%
Aggressive Subtypes
11%
CDNA Microarray
11%
Potential Biomarkers
11%
Receptor-interacting Protein Kinase 1 (RIPK1)
11%
Neuron-specific Enolase
11%
Neuroendocrine Phenotype
11%
Serum-free Medium
11%
Highly Aggressive
11%
Androgen Ablation Therapy
11%
Lysosomal Stability
11%
Medicine and Dentistry
Autophagy
100%
Prostate Cancer
100%
Neuroendocrine Differentiation
100%
Upregulation
42%
Western Blot
28%
Cell Survival
28%
Quantitative Reverse Transcription Polymerase Chain Reaction
28%
Protein Kinase B
28%
Beclin 1
28%
Cancer Cell
14%
Gene Expression
14%
Tubulin
14%
Cell Differentiation
14%
Confocal Microscopy
14%
Small Interfering RNA
14%
Androgen Receptor
14%
Biological Marker
14%
Androgen
14%
cDNA Microarray
14%
Ablation Therapy
14%
Neuron Specific Enolase
14%
Receptor Protein
14%
Lysosome Associated Membrane Protein 2
14%
Messenger RNA
14%
Lysosomal Membrane Protein
14%
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
LNCaP
100%
LAMP2
100%
Neuroendocrine Cell
75%
Upregulation
37%
Protein Kinase B
25%
Cell Survival
25%
Western Blot
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Cancer Cell
12%
Gene Expression
12%
Tubulin
12%
Cellular Differentiation
12%
Small Interfering RNA
12%
Confocal Microscopy
12%
ATG5
12%
Androgen Receptor
12%
cDNA Microarray
12%
Enolase
12%
Messenger RNA
12%
Lysosomal Membrane Protein
12%